Trial intelligence / Profile preview

Menatetrenone for Fracture Prevention in Osteoporosis (OF Study)

NCT00165607Phase 4Completed

Sponsor
Eisai Co., Ltd.
Start
Apr 1996
Primary completion
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of menatetrenone in osteoporosis, sponsored by Eisai Co., Ltd.. Started Apr 1996; status: completed.

02

Drugs

menatetrenone
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT00165607.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00165607.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call